|Bid||2.2500 x 1100|
|Ask||2.2700 x 1300|
|Day's Range||2.2100 - 2.3100|
|52 Week Range||0.8800 - 4.3400|
|Beta (5Y Monthly)||1.13|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 15, 2022 - Aug 20, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||11.75|
Pfizer (PFE) submits NDA to the FDA seeking approval for using its oral antiviral COVID pill in vaccinated and unvaccinated patients at a high risk of developing severe COVID-19 complications.
Aridis Pharmaceuticals (ARDS) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Endo International (ENDO) tanks 26%, cooling off after its massive stock price surge on Tuesday, post the Supreme Court's decision to overturn Roe v. Wade.